Theriva Biologics에 대한 매도 수량은 투자자에게 Theriva Biologics의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Theriva Biologics (AMEX:TOVX) 주식, 공매도 수량 보고

Theriva Biologics

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics Inc

The Brazilian mining giant Vale SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) announced its commitment to significantly boost <a href="https://www.benzinga.com/topic/copper">copper</a> production under its new CEO, Gustavo Pimenta.
Pimenta, a former CFO who became CEO after a <a href="https://www.benzinga.com/news/24/08/40597248/vale-selects-cfo-gustavo-pimenta-as-new-ceo-ending-turbulent-succession-process">turbulent succession process</a>, spoke to the media for the first time in his new role. He <a href="https://www.bloomberg.com/news/articles/2024-10-02/vale-backs-brazil-critical-minerals-fund-in-nod-to-government">acknowledged</a> that Vale has "fallen behind on copper " compared to industry peers but plans to close that gap, Bloomberg reported.
This year, Vale expects to produce between 320,000 and 355,000 metric tons of copper — well below the output of its size-related industry peers. Pimenta plans to raise the output of its assets in Brazil, Canada and Indonesia to around 500,000 tons before considering other options.
In addition to growing copper production, Vale focuses on investments in strategic minerals essential for the global energy transition. The firm has been under pressure from the Brazilian government, which pleaded for increased domestic investments.
In collaboration with Brazil's development bank, BNDES, Vale will invest around $184 million in junior and mid-sized companies working on minerals like nickel and cobalt — crucial for electric vehicles and renewable energy technologies.
Despite these ambitions, Vale faces several challenges. As the largest iron ore producer globally, the firm has experienced a slowdown in China's economy, a critical market for that commodity. Additionally, the aftermath of the catastrophic 2015 dam collapse still requires <a href="https://www.benzinga.com/markets/equities/24/01/36799749/brazilian-judge-slams-mining-giants-vale-and-bhp-with-9-67b-charges-over-dam-collapse-report">substantial financial and legal settlements</a>, creating a drain on the firm's resources.
However, Vale's rapidly evolving copper market peers are not sitting idle. Barrick has been ramping production and <a href="https://www.benzinga.com/news/24/09/40851842/barrick-to-complete-feasibility-study-for-lumwana-mine-expansion-start-construction-in-2025">investing $2 billion </a>in expansion at its Lumwana mine in Zambia, which is set to double copper output to 240,000 tons per year by 2028. Barrick is also advancing its Reko Diq project in Pakistan, further boosting its copper and gold production.
Meanwhile, Australian miner BHP has identified copper as a <a href="https://www.benzinga.com/news/large-cap/24/10/41114374/bhp-sees-trend-reversal-in-copper-growth-warns-recycling-wont-be-enough">key growth pillar</a>, anticipating a 70% increase in global demand by 2050. BHP is expanding its copper portfolio, focusing on existing operations and potential new projects like Oak Dam in Australia, addressing aging mines and declining ore grades.
With copper touted as a cornerstone metal for the green tech transition, Vale's new management has a lot of ground to cover before catching up to its competitors which are committed to multi-billion-dollar projects.
Read Next: • <a href="https://www.benzinga.com/government/24/10/41172781/oil-prices-rally-biden-confirms-us-discussions-with-israel-about-striking-iran-facilities">Oil Prices Rally: Biden Confirms US &#8216;Discussions&#8217; With Israel About Striking Iran Facilities</a>
Photo: Shutterstock

Large Cap

News

Commodities

Global

Trading Ideas

VALE

Vale Plans To Expand Copper Output, Invests $184M For Domestic Critical Minerals

BIC is making headlines again with the launch of the limited-edition &#8220;Hold the Phone&#8221; Case by BIC EZ Reach Lighters.
The company announced its multi-year partners &#8211; Snoop Dogg and Martha Stewart – are an inspiration for the two phone cases matching the celebrity duo&#8217;s iconic signature BIC EZ Reach Lighter designs.
Jeany Mui, marketing director at BIC Flame for Life, said the &#8216;Hold the Phone&#8217; Cases by BIC EZ Reach Lighters celebrate the collaboration with Stewart and Snoop.
&#8220;Building on the success of our previous campaigns and the legendary pair&#8217;s undeniable chemistry, we&#8217;re thrilled to launch another must-have accessory ahead of the holiday season,&#8221; Mui said.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03165146/ccc-oct-24-banner__1_-7.gif" alt="" class="wp-image-579538" /></a></figure>
BIC previously reintroduced its EZ Reach Lighters&#8217; &#8220;Most Borrowed&#8221; campaign in early 2014, featuring <a href="http://benzinga.com/topic/willie-nelson" target="_blank" rel="noreferrer noopener">Willie Nelson</a>, <a href="http://benzinga.com/topic/Snoop-Dogg" target="_blank" rel="noreferrer noopener">Snoop Dogg</a> and <a href="http://benzinga.com/topic/martha-stewart" target="_blank" rel="noreferrer noopener">Martha Stewart</a>. The campaign has driven remarkable consumer sentiment and a notable increase in <a href="https://www.benzinga.com/markets/cannabis/24/01/36616705/snoop-dogg-willie-nelson-and-martha-stewart-team-up-in-new-bic-lighters-ad-bic-executive-explain">year-over-year sales since its inception.</a>
The illustrious trio teamed up this past April yet again to promote its EZ Reach lighter and to celebrate the 4/20 cannabis holiday.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Launched at 4:20 pm on 4/20, the event, titled the "Slow Burn Sessions," featured the trio for 4 hours and 20 minutes of exclusive content on <a href="https://www.youtube.com/@bicbrand">Bic's YouTube channel</a> all weekend, giving viewers a chance to unwind with three mood-setting segments, representing each <a href="https://www.benzinga.com/markets/cannabis/24/04/38346359/snoop-dogg-willie-nelson-and-martha-stewart-light-up-on-420-with-bics-slow-burn-sessions-heres-h">celeb and with its own flare.</a>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/04/31911647/exclusive-where-is-snoop-doggs-ez-reach-lighter-bic-lights-up-america-to-find-out-in-a-420-campa">Exclusive: Where Is Snoop Dogg&#8217;s EZ Reach Lighter? BIC Lights Up America To Find Out In A 4/20 Campaign Featuring Willie Nelson And Martha Stewart</a>
Stewart said in the press release she's keeping BIC EZ Reach Lighter designs close. "I keep one of my own BIC EZ Reach Lighter designs in nearly every room of my home, and with the launch of our &#8216;Hold the Phone&#8217; by Case by BIC EZ Reach Lighters, I can easily bring my favorite lighters with me on-the-go."
<h3 class="wp-block-heading">Where To Find The New Accessory?</h3>
As of Friday, Oct. 4, consumers can exclusively head to BIC&#8217;s website to purchase the limited-edition iPhone 15-compatible Martha Stewart or Snoop Dogg-themed &#8220;Hold the Phone&#8221; Cases by BIC EZ Reach Lighters.
Each case &#8211; priced at $49.99 &#8211; includes two BIC EZ Reach Lighters based on the case design selected.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/40047948/snoop-dogg-rolls-out-first-cannabis-coffeeshop-in-amsterdam-its-only-right-that-i-bring-s-w-e-d-">Snoop Dogg Rolls Out First Cannabis Coffeeshop In Amsterdam: &#8216;It&#8217;s Only Right That I Bring S.W.E.D. Global To This Iconic City&#8217;</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/11/36002268/martha-stewart-and-canopy-growth-launch-new-cbd-gummies-just-in-time-for-the-holidays">Martha Stewart And Canopy Growth Launch New CBD Gummies Just In Time For The Holidays</a></li>
</ul>

Cannabis

Entertainment

Entrepreneurship

Retail Sales

BIC Rolls Out Snoop Dogg And Martha Stewart-Inspired Limited-Edition Accessory, Here's Where To Find It

Social media company Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has paid out over $2 billion to content creators this year as it works to boost monetization efforts for <a href="https://www.benzinga.com/news/24/04/38085248/instagram-creators-can-now-earn-upto-30k-in-a-month-with-reels-photo-carousels-and-more-as-meta-revi">users of the platform.</a>
Here's a look at what the company has done and what's next.
 What Happened: Meta Platforms&#8217; Facebook began monetization efforts in 2017 because it wanted to compete with other social media platforms and<a href="https://www.benzinga.com/topic/youtube"> video outlets such as YouTube.</a>
The company has paid out $2 billion over the last year with payouts for short-form videos and Reels up 80% year-over-year, as <a href="https://techcrunch.com/2024/10/02/facebook-says-it-paid-content-creators-2b-this-year/">reported </a>by TechCrunch.
Facebook said that more than four million content creators have earned money from the platform since 2017.
While the $2 billion figure is large and could be eye-catching to lure content creators to Facebook, the figure is a fraction of the $70 billion paid out by YouTube to content creators over the last three years as part of its partner program, TechCrunch reported.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent100324">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
 What's Next: To help grow its content creation, Meta announced several changes this week.
The company is <a href="https://about.fb.com/news/2024/10/monetize-content-facebooks-new-streamlined-program/">rolling </a>out Facebook Content Monetization, which combines three existing creator monetization efforts (in-stream ads, ads on Reels, Performance bonus) into one platform.
Creators on the new platform can earn from photos, text posts, short videos and longer videos, according to the company.
"We're proud of how our monetization programs have helped creators thrive on Facebook, but we know that the different availability, eligibility requirements and sign-up processes of our various programs have resulted in some creators missing opportunities and other not being eligible to earn from all available formats," the company said.
With the new platform, creators only have to join one platform with several ways to monetize their content.
The company sent out invitations to one million creators as part of the content monetization beta launch. Additional invitations will be sent in the "following months."
Open enrollment for the content monetization platform begins in 2025.
META Price Action: Meta stock closed Monday up 1.74% to $582.77 on Thursday versus a 52-week trading range of $279.40 to $583.36. Meta stock is up 68.3% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/10/41150827/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-september-2024-where-do-tesla-nvidia-apple">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?</a></li>
</ul>
Photo: Shutterstock

Social Media

Tech

Mark Zuckerberg's Facebook Paid $2B To Content Creators In The Past Year — And It Wants To Pay Out More

Afrimat (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AFTLF#OTC">AFTLF</a>) is known for its operations in lime, iron ore, anthracite and manganese, has made a move into the hemp industry by partnering with legacy brand Hemporium.
Together, they are using hemp-based materials to expand a building in Cape Town. This venture raises questions: is Afrimat betting on the future of South Africa&#8217;s hemp industry, or is it a PR stunt?
The investment comes at a time when South Africa is pushing to grow the sector, having recently issued 1,110 permits for hemp cultivation as part of the government&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/09/40887359/south-africa-issues-1-110-hemp-licenses-is-the-industry-leaving-small-farmers-behind">master plan</a> under the Cannabis for Private Purposes Bill.
Afrimat's involvement could provide the industry with <a href="https://www.benzinga.com/markets/cannabis/24/07/39824908/south-african-companies-prepare-for-new-cannabis-regulations-experts-expect-lots-of-fundraising-">much-needed capital to scale</a>.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Afrimat's Green Transition</h3>
Afrimat's collaboration with Hemporium signals the company's interest in sustainability.&nbsp;
Beyond its mining operations, the publicly-traded Afrimat has been working on renewable energy initiatives, recycling mining by-products and rehabilitating mined-out areas through reforestation and water conservation projects, <a href="https://hemptoday.net/what-is-a-mining-conglomerate-like-south-africas-afrimat-doing-in-industrial-hemp/">reported</a> Hemp Today. 
Mining operations for materials like lime, iron ore, anthracite and manganese have significant environmental impacts. Iron ore mining, for example, can <a href="https://link.springer.com/article/10.1007/s11270-024-07048-x">contaminate water sources </a>through increased sediment levels and metal runoff, while the removal of vegetation for mining operations drastically reduces biodiversity. <a href="https://link.springer.com/chapter/10.1007/978-3-030-38152-3_8">Limestone mining </a>similarly contributes to environmental degradation by altering land-use patterns and causing dust and noise pollution, which can harm local ecosystems and communities. 
Read Also:&nbsp;<a href="https://www.benzinga.com/general/biotech/24/07/39894649/the-wall-that-can-withstand-1700-f-and-cut-10b-in-losses-fire-resistant-hempcrete-now-certified">The Wall That Can Withstand 1700°F And Cut $10B In Losses: Fire-Resistant Hempcrete Now Certified</a>
<h3 class="wp-block-heading">Hemp Town</h3>
The hemp-lime block technology used in Cape Town, combined with specialized binders, promises to offer a sustainable alternative in the construction industry.&nbsp;
Hemporium and <a href="https://www.afrimathemp.co.za/">Afrimat Hemp</a>, a subsidiary of Afrimat, are nearing the completion of a seven-story expansion on an existing five-story building. The new structure, built with 28 cm-thick hemp blocks, will bring the building's total height to 12 stories.&nbsp;
The space will house Hemporium's flagship retail outlet, where they will sell<a href="https://www.benzinga.com/topic/hemp"> hemp-derived</a> clothing, skincare and CBD products, along with a steak restaurant and 50 hotel rooms.
The walls are built with <a href="https://www.benzinga.com/general/biotech/24/02/37271000/u-s-army-invests-1-9m-to-develop-hemp-manufactured-buildings-for-military-operations">hempcrete blocks</a>, made by Afrimat Hemp from European hemp hurd and locally sourced lime, capable of withstanding fire for 135 minutes.
The building also features solar panels, smart metering, a borehole with filtration for backup water and a thermally activated building system (TABS) to regulate temperature without mechanical heating or cooling.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40756333/gov-newsom-proposes-emergency-rules-to-severely-restrict-hemp-products-this-will-destroy-our-bus">Gov. Newsom&#8217;s Total Ban On Hemp THC Could Crush California&#8217;s Billion-Dollar Industry, Say Stakeholders (UPDATED)</a>
<h3 class="wp-block-heading">How Is Concrete Made Out Of Hemp? </h3>
Hempcrete, a <a href="https://www.benzinga.com/markets/cannabis/24/07/40027836/hempcrete-project-gets-6-2m-epa-grant-to-develop-eco-friendly-construction-materials">sustainable building material</a>, begins with harvesting the stalks of the hemp plant. Once harvested, the stalks are left on the ground for 10 to 14 days to degrade the outer fibers. This microbial breakdown helps release the inner woody core, known as the hemp hurd, which is the essential construction material.
After this process, the <a href="https://www.benzinga.com/topic/hemp">hemp</a> stalks are collected, crushed and sorted to separate the fiber from the hurd. The hurd, chopped into small particles (typically around 1 inch), is cleaned to remove dust, ensuring the quality of the material.
The next step involves mixing the processed hemp hurd with lime and water. The typical ratio is three parts hemp, one part lime, and one part water, although these proportions can vary depending on the humidity and specific requirements of the project. This mixture is then used to create blocks or panels for construction.
In some cases, the mixture is poured into molds to make bricks, which are compacted and allowed to air dry or placed in an oven. Alternatively, for larger structures, the mixture can be poured directly into formwork to create whole walls, reducing the need for individual brick assembly.
Hempcrete is known for being lightweight &#8211; 50% lighter than traditional concrete &#8211; and ten times more insulating, offering an eco-friendly and flexible building solution. 
Read Next:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/22/02/25762696/is-hempcrete-the-new-green-construction-material-it-could-soon-be-approved-as-just-that">Is Hempcrete The New Green Construction Material? It Could Soon Be Approved As Just That</a>

Biotech

Market Summary

Emerging Markets

Contracts

Success Stories

Markets

General

AFTLF

Publicly Traded South African Mining Co. Invests In Fire-Resistant Hemp Buildings - New Industry Or PR Stunt?

The upfront cash payment brings non-dilutive capital to Editas Medicine, helping enable further pipeline development and related strategic priorities.
Under the terms of the agreement, Editas Medicine will receive an upfront cash payment of&nbsp;$57 million&nbsp;in exchange for up to&nbsp;100%&nbsp;of certain future annual license fees payable to Editas Medicine, ranging from&nbsp;$5 million&nbsp;to&nbsp;$40 million&nbsp;per year (inclusive of certain sales-based annual license fees that may become due) and a mid-double-digit percentage of Editas Medicine&#39;s portion of a&nbsp;$50 million&nbsp;contingent upfront payment for which Editas Medicine is eligible under the Vertex license agreement.
In addition to a portion of any such contingent upfront payment, Editas Medicine retains rights to fixed annual license fees for 2024 and a mid-single-digit million-dollar payment due to Editas Medicine in the event of Vertex&#39;s achievement of certain annual sales milestones.

Asset Sales

EDIT

Editas Medicine Reports Sale Of Certain Future License Fees, Other Payments Owed Under Cas9 License Agreement With Vertex To DRI Healthcare Trust Subsidiary For Upfront Cash Payment Of $57M

LGIH

LGI Homes Says It Closed 579 Homes In September, Up 7.2% Y/Y, Resulting In Total Of 1,757 Homes Closed During Q3

The deal includes an exclusive license to manufacture, upgrade, and repair the product line. The agreement also grants IS&amp;S exclusive intellectual property rights and includes the transfer of existing inventory necessary for continued manufacturing and support of the products.
This acquisition significantly expands IS&amp;S&#39;s capabilities and enhances its presence within the military aviation sector. Following a transition period, IS&amp;S, will be responsible for the activities formerly performed by Honeywell.

ISSC

Innovative Solutions & Support Buys License For Various Generations Of Military Display Generators And Flight Control Computers From Honeywell; No Terms Disclosed

For the three months ended September 30, 2024, the Company had an average of 107 drilling rigs operating in the United States.

PTEN

Patterson-UTI Reports Average Of 107 Drilling Rigs Operating In US For September

Despite achieving <a href="https://www.benzinga.com/markets/cannabis/24/04/38076225/another-record-breaking-month-for-new-mexicos-cannabis-industry-heres-how-much-retailers-garnere">over $1 billion in sales</a> since the legalization of recreational cannabis 29 months ago, New Mexico&#8217;s cannabis industry is grappling with severe regulatory challenges. A year-long <a href="https://www.krqe.com/news/larry-barker/the-new-mexico-cannabis-cowboys-modern-day-desperados/">investigation</a> by KRQE&#8217;s Larry Baker has uncovered serious regulatory issues in <a href="https://www.benzinga.com/topic/new-mexico-cannabis">New Mexico's cannabis industry</a>, which has attracted lawbreakers and crime networks.&nbsp;
<h2 class="wp-block-heading">Lack Of Regulatory Oversight</h2>
According to the report, the Cannabis Control Division (CCD) is under-resourced, with only nine inspectors overseeing 3,000 licensed cannabis businesses. This understaffing has led to a situation where many operations go uninspected, allowing criminal enterprises, some linked to international criminal networks in Mexico and <a href="https://www.benzinga.com/markets/cannabis/24/06/39559399/new-mexicos-dark-discovery-chinese-workers-trapped-on-illegal-cannabis-farms">China</a>, to thrive without scrutiny. This loophole could be the result of the state&#8217;s licensing process.
In a podcast <a href="https://www.krqe.com/podcasts/the-growing-black-market-inside-new-mexicos-cannabis-industry/">interview</a> with KRQE, Duke Rodriguez, CEO of Ultra Health, New Mexico's largest cannabis operator, highlighted the gravity of the situation, revealing that two-thirds of the state's cannabis activity remains illicit. He criticized the state&#8217;s licensing system, describing it as an ineffective &#8220;honor system,&#8221; where applicants are granted licenses with the assumption they won&#8217;t violate regulations.
Rodriguez explained that inspections occur only after the license is issued and the business is already operational. The state can only intervene if irregularities are found during these inspections. "You won't see that anywhere else in the country," added Larry Barker, noting that enforcement delays often mean businesses can operate for 12 to 18 months without proper oversight.
<h3 class="wp-block-heading">Change In The State&#8217;s Regulatory Approach</h3>
Rodriguez also pointed out that under the old <a href="https://www.benzinga.com/markets/cannabis/22/04/26481542/new-mexico-legal-cannabis-program-up-and-running-raking-in-millions">medical cannabis program</a>, such infractions would have led to immediate license suspension or revocation. However, since <a href="https://www.benzinga.com/markets/cannabis/21/04/20589377/adult-use-cannabis-is-now-legal-in-new-mexico-gov-signs-legalization-expungement-bills">recreational cannabis legalization</a>, the lack of enforcement has allowed illegal operations to flourish unchecked. &#8220;The lack of enforcement is hurting the state&#8217;s economy,&#8221; he said, adding that the regulated market struggles to compete with its illicit counterpart.
"The state simply took its hands off the steering wheel … just issue a license to anyone who marked the boxes. And that's what they did," Rodriguez said. He added that while Governor Michelle Lujan Grisham celebrated the state surpassing $1 billion in legal cannabis sales in March 2024, most of the sales figures were tied to political optics rather than a reflection of a healthy market.The CCD's limited ability to collect fines or shut down rogue operations further complicates the situation.
<h3 class="wp-block-heading">Systemic Lack Of Enforcement</h3>
Barker's investigation found that only about 10% of cannabis businesses consistently comply with reporting regulations. Even when the CCD takes action, it struggles to enforce penalties. Barker cited one <a href="https://www.benzinga.com/markets/cannabis/24/01/36473694/new-mexico-clamps-down-2m-fines-for-cannabis-farm-violations">cannabis farm fined $1 million</a> for rule violations, but it remains unpaid and the farm is still operational. "They have the authority to issue fines but not to collect them," Barker explained, highlighting the regulatory division's limited power.
Rodriguez echoed these concerns, saying that the state's lack of enforcement has fostered a rampant illicit market. "We're just creating this overly illegal, illicit black market," he said, noting that the number of rogue operations likely extends beyond what has been uncovered.
Cover image made with AI

Regulations

New Mexico's Cannabis Industry Struggles Against Criminal Exploitation And Regulatory Failures

Bristol Myers Squibb Says FDA Approved Perioperative Treatment Of Neoadjuvant Opdivo (Nivolumab) And Chemotherapy Followed By Surgery And Adjuvant Single-Agent Opdivo For Resectable Non-Small Cell Lung Cancer

Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) and Constellation Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) shares traded higher Thursday after RBC Capital raised price targets on both stocks amid growing demand for energy to power data centers and<a href="https://www.benzinga.com/news/24/09/41032700/whats-going-on-with-vistra-stock"> other AI infrastructure. </a>
The Details: Energy stocks continue to climb as demand for electricity to power data centers and other AI applications soars. Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) CEO Sundar Pichai told Nikkei in <a href="https://asia.nikkei.com/Editor-s-Picks/Interview/Google-considers-sourcing-from-nuclear-power-plants-says-CEO-Pichai">an interview </a>on Thursday that Google is considering powering its data centers with nuclear power plants. 
Constellation Energy already signed a 20-year nuclear power<a href="https://www.benzinga.com/markets/equities/24/09/40957437/microsoft-taps-constellation-for-20-year-carbon-free-power-3-400-jobs-coming-to-pennsylvania"> purchase agreement</a> with Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) to deliver clean energy to its AI infrastructure. The comments from Google's CEO suggest other AI hyper-scalers may follow the same path. 
Read Next: <a href="https://www.benzinga.com/news/24/10/41152629/what-happened-with-accenture-stock-today">What Happened With Accenture Stock Today?</a>
RBC Capital analyst Shelby Tucker maintained Vistra with an Outperform and raised the price target on the stock from $105 to $141. The RBC analyst also maintained a Sector Perform rating on Constellation Energy and raised its price target from $214 to $272 on Thursday.
Vistra was the best performer in the S&amp;P 500 Index on Thursday and remains the best performer in the S&amp;P 500 year-to-date. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Vistra has jumped 243% in 2024 and Constellation Energy is up 137% year-to-date.&nbsp;
VST, CEG Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Vistra shares ended Thursday's session up 5.65% at $132.45 and Constellation Energy shares closed up 4.52% at $277.37.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41122476/whats-going-on-with-microstrategy-stock">What&#8217;s Going On With MicroStrategy Stock?</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Analyst Ratings

Movers

GOOG

GOOGL

MSFT

What Happened With Vistra, Constellation Energy Stocks Today?

Cannabis consumption provides medicinal benefits, even when deemed recreational. Whether for pain, stress, anxiety or sleep, consumers' motivations often overlap across both categories.
Recent research from<a href="https://newfrontierdata.com/"> New Frontier Data </a>looks at how these motivations blur traditional distinctions between medical and recreational marijuana use, challenging perceptions about their differences.
As the cannabis industry grows, this overlap becomes even more significant. Investors who understand these shifting behaviors and evolving legal frameworks in each state will be best positioned to capitalize on the next wave of growth opportunities.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">New Frontiers For Cannabis&nbsp;</h3>
The study surveyed 3,868 U.S. cannabis consumers, asking them to classify their use as medical, recreational, or both. It analyzed consumption patterns, demographics, and spending habits, offering key insights into what drives different types of users.&nbsp;
This data sheds light on consumer behavior and its impact on market trends.
States like <a href="https://www.benzinga.com/topic/ohio-cannabis">Ohio</a> have already transitioned to recreational cannabis, while <a href="https://www.benzinga.com/topic/florida-cannabis">Florida</a>, is poised for legalization in 2024 if a ballot initiative is approved. <a href="https://www.benzinga.com/topic/arkansas-cannabis">Arkansas</a>, <a href="https://www.benzinga.com/topic/nebraska-cannabis">Nebraska</a>, <a href="https://www.benzinga.com/topic/south-dakota-cannabis">South Dakota</a>, and <a href="https://www.benzinga.com/markets/cannabis/24/07/39602457/majority-of-north-dakotans-are-against-legal-weed-new-poll-finds">North Dakota</a> are also advancing ballot initiatives. <a href="https://www.benzinga.com/topic/pennsylvania-cannabis">Pennsylvania</a> and <a href="https://www.benzinga.com/topic/wisconsin-cannabis">Wisconsin</a> are pushing forward despite political challenges.
<h3 class="wp-block-heading">Gender Differences And Consumer Behavior</h3>
According to the survey, women make up 46% of the cannabis consumer base and are more likely than men to use cannabis solely for medical purposes. However, both genders report similar rates of recreational use. 
Additionally, home growers, though representing a minority at 54% of non-growers, are significantly more likely to use cannabis for both medical and recreational purposes​. 
"Market type is significantly correlated with <a href="https://www.benzinga.com/markets/cannabis/24/05/38972587/who-is-buying-marijuana-and-why-market-data-provides-behavior-profiles-insights-for-investors">self-identified consumer type</a>. It is interesting to note that, even in medical-only markets, 27% of consumers consider themselves recreational only," reads the report.&nbsp;
<h3 class="wp-block-heading">Who Spends The Most? </h3>
Medical-only consumers exhibit higher<a href="https://www.benzinga.com/markets/cannabis/24/06/39540101/budget-conscious-consumers-boost-sales-of-marijuana-multipacks-94-brands-vie-for-colorados-pre-r"> spending habits</a>, with many spending over $400 per purchase. By contrast, recreational consumers typically spend under $50, with some even obtaining cannabis for free. This discrepancy highlights the deeper financial commitment of those using cannabis for medical reasons, often tied to long-term therapeutic needs.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40533363/how-seo-trauma-is-costing-weed-brands-70-of-sales-and-why-most-dispensaries-fail-jp-donahue-unle">How SEO Trauma Is Costing Weed Brands 70% Of Sales —And Why Most Dispensaries Fail: JP Donahue Unleashed</a>
<h3 class="wp-block-heading">How Often?&nbsp;</h3>
Those who use cannabis for both medical and recreational purposes consume more frequently, often <a href="https://www.benzinga.com/markets/cannabis/24/02/37221610/how-many-joints-a-day-are-safe-researchers-identify-methods-for-weed-consumption-within-healthy-">multiple times per day</a>, while recreational-only users tend to consume the least. The report found that medical users are far more likely to report positive impacts on their lives from cannabis use, whereas recreational users often cite a mixed effect.
<h3 class="wp-block-heading">Market Loyalty</h3>
Medical users also show greater loyalty to specific businesses, purchasing from the same source for product consistency and reliability. In contrast, recreational users are less likely to stick with one store, leaning toward more varied buying habits. 
This difference underscores the need for reliable, consistent products in medical marijuana markets.
&#8220;Medical-only consumers were the most likely to say that they always source their <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37666783/marijuana-shoppers-favorite-strains-2024">cannabis from the same business</a>, while recreational-only consumers were the most likely to say they buy from different stores. This reflects the need of medical consumers to have consistent access to the same products,&#8221; reads the report.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/10/41154738/ohio-cannabis-market-soars-to-76m-in-less-than-2-months-but-michigan-remains-the-leader">Ohio Cannabis Market Soars To $76M In Less Than 2 Months But Michigan Remains The Leader</a>

Guidance

Management

What's The Difference Between Medical And Recreational Cannabis Users? New Survey Reveals Market Trends

Vizimax is a provider of innovative solutions to measure, control and switch high- and medium-voltage electric power systems.
Headquartered in Longueuil, Quebec, Vizimax is led by President Jean-Guy Lacombe and was previously owned by a group of investors led by BDC Capital and Yaletown Ventures.
&nbsp;

Blackstone Portfolio Company Power Grid Components Acquires Vizimax; No Terms Disclosed

IonQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares are bouncing around in Thursday&#8217;s after-hours session after the company announced it reached a significant milestone in developing networked <a href="https://www.benzinga.com/pressreleases/24/10/b41173403/ionq-demonstrates-remote-ion-ion-entanglement-a-significant-milestone-in-developing-networked-quan">quantum systems at scale</a>.
What Happened: After the market close on Thursday, IonQ said it successfully demonstrated remote ion-ion entanglement, crossing off another milestone of its scaling strategy.
IonQ announced it achieved ion-photon entanglement in February. The remote ion-ion entanglement marks the second of four significant milestones required to develop photonic interconnects and take a foundational step towards quantum networking.
&#8220;IonQ&#8217;s north star remains scalability at high performance, and the progress we&#8217;ve made towards photonic interconnects ensures our customers will have access to large quantum systems capable of tackling the most complex problems,&#8221; said Peter Chapman, president and CEO of IonQ.
&#8220;We&#8217;re consistently making significant headway on our technical roadmap, and customers across academia and business recognize the unique value IonQ&#8217;s systems bring as we near the point of commercial quantum advantage.&#8221;
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41037763/kamala-harris-strengthens-crypto-stance-the-us-will-remain-dominant-in-ai-and-quantum-comp">Kamala Harris Strengthens Crypto Stance: The US Will &#8216;Remain Dominant In AI And Quantum Computing, Blockchain, And Other Emerging Technologies&#8217;</a>
The news comes less than a week after the company <a href="https://www.benzinga.com/markets/equities/24/09/41071006/why-is-ionq-stock-trading-higher-on-friday">announced</a> that it signed a $54.5 million contract with the U.S. Air Force Research Lab and said it remains on track to nearly double its revenue for the third year in a row. IonQ shares are up about 15% since the announcement. 
IonQ is scheduled to <a href="https://x.com/IonQ_Inc/status/1840843273352679778">host a session</a> with data software company Evidentli on Oct. 11. The session will focus on the transformational potential quantum computing offers to the pharmaceutical industry. 
According to the <a href="https://www.eventbrite.com.au/e/generative-ai-20-for-data-harmonisation-and-federated-analytics-tickets-1026755763127">event listing</a>, presenters will talk about how new generative AI approaches can transform real-world data 250 times faster than current methods.
IONQ Price Action: <a href="http://benzinga.com/quote/ionq">IonQ shares</a> closed Thursday up 0.54%. The stock was up another 0.54% in after-hours, trading at $9.30 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Courtesy of IonQ.

After-Hours Center

IONQ

What's Going On With IonQ Stock Thursday?

Retail industry veteran Seth Golden recently warned that, according to a widely used oscillator Williams %R, the <a href="https://www.benzinga.com/topic/s-p-500">S&amp;P 500</a> has been overbought for an entire year.
Golden, a hedge fund consultant who previously worked for household names such as Target and now-defunct Bed Bath &amp; Beyond, pointed out that this is just the 23rd time in history that this has occurred.
Based on historical data he shared in a post on <a href="https://x.com/SethCL/status/1841808020705075700">X</a>, he pointed out that when this happened, it continued the same trend for the rest of the year — posting a fourth-quarter median return of 5.29%.
<a href="https://www.benzinga.com/11/04/1035270/pros-and-cons-of-williams-r-indicator">Williams %R</a>, often dubbed the Williams percent range, is a momentum indicator. It measures the overbought and oversold levels on a scale from 0 to 100. A reading above -20 is overbought and a reading below -80 is oversold.
Golden used a 28-month parameter, an industry standard for this indicator.
See Also: <a href="https://www.benzinga.com/general/travel/24/10/41172625/will-airlines-soar-or-stall-what-insider-trades-say-about-airline-industrys-future">Will Airlines Soar Or Stall? What Insider Trades Say About Industry&#8217;s Future</a>
Looking deeper into the list of overbought stocks brings an interesting mix of domestic and foreign catalysts.
Lockheed Martin's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) presence on this list is unsurprising. The leading aerospace and defense manufacturer&#8217;s stock hit a fresh all-time high, reaching $609 and giving it a market cap of over $144B. The firm benefits from increased defense spending during <a href="https://www.benzinga.com/news/global/24/10/41126038/iran-attacks-israel-with-missiles-middle-east-tensions-escalates-s-p-500-stocks-bitcoin-fall-as-oil">escalating global conflicts</a> and with a <a href="https://www.benzinga.com/news/earnings/24/10/41164528/lockheed-wins-2-1b-contract-to-aid-trident-ii-d5-missile-program">new multi-billion U.S. Navy contract</a> it landed last Thursday. Despite a hefty $19.26B debt, the firm has the balance sheet to easily manage it, plus pay a reliable 2.1% dividend. Its Williams %R overbought score is currently -11.41.
Next on the list is Lowe's Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>), a North Carolina-based retailer specializing in home improvement. It recently hit a new all-time high of $274.16. Along with other home improvement stocks, Lowe <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41008424/lowes-set-for-delayed-benefits-from-macro-demand-improvements-says-optimistic-analy">experienced a surge</a> following the FED's rate cut. Still, this strong performance is surprising, given the firm's revenue decline of nearly 10% year over year and dimmed future growth projections. Its Williams %R overbought score is currently -5.71.
Entergy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) has been a utility industry standout, delivering an almost 30% return year-to-date. Despite such numbers, the stock trades at a reasonable P/E ratio of 15.9x, below some of its peers like Exelon or FirstEnergy.
Entergy provides electric power to the southern U.S. states, benefiting from rapid energy growth in states such as Texas. Investors expect the company to scale with its target market, with a booming population and increased industrial activity prompting higher energy consumption. The stock's Williams %R overbought score currently stands at -7.41.
Read Next: <a href="https://www.benzinga.com/government/24/10/41172781/oil-prices-rally-biden-confirms-us-discussions-with-israel-about-striking-iran-facilities"> •&nbsp;Oil Prices Rally: Biden Confirms US &#8216;Discussions&#8217; With Israel About Striking Iran Facilities</a>
Photo: Shutterstock

Equities

Why S&P 500's Year-Long Overbought Signal Has This Expert Talking, Plus 3 Stocks To Watch

Restricted subsidiary Calumet Montana Refining, LLC (&quot;CMR&quot;) entered into a new agreement with Stonebriar in which CMR sold certain of its assets to Stonebriar for&nbsp;$150 million&nbsp;and leased back the same assets.

CLMT

Calumet Reveals Series Of Related Agreements With Stonebriar Commercial Finance

NewMarket Says William Skrobacz Is Stepping Down From His Role As Vice President And CFO, Effective December 31, 2024, As He Intends To Retire From Company In 2025; Timothy Fitzgerald Named As Successor

ConRes Test Equipment generates approximately&nbsp;$12 million&nbsp;in annual sales and is expected to be immediately accretive to DSG&#39;s adjusted EBITDA margins on a go-forward basis.
The transaction will be funded through DSG&#39;s existing cash and availability under its credit agreement and is expected to close in the&nbsp;fourth quarter&nbsp;of 2024, subject to customary closing conditions.
This acquisition is not expected to be material for financial reporting purposes to DSG&#39;s results.

DSGR

Distribution Solutions Group's TestEquity Agrees To Acquire ConRes Test Equipment; No Terms Disclosed

Under the agreement, TSMC will contract turnkey advanced packaging and test services from Amkor in their planned facility in Peoria, Arizona.
TSMC will leverage these services to support its customers, particularly those using TSMC&#39;s advanced wafer fabrication facilities in Phoenix.
The close collaboration and proximity of TSMC&#39;s front-end fab and Amkor&#39;s back-end facility will accelerate overall product cycle times.

AMKR

Amkor Technology, TSMC Sign MoU To Collaborate And Bring Advanced Packaging And Test Capabilities To Arizona

5 analysts have shared their evaluations of Liberty Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Liberty Energy and provided 12-month price targets. The average target is $23.6, accompanied by a high estimate of $26.00 and a low estimate of $20.00. Experiencing a 7.81% decline, the current average is now lower than the previous average price target of $25.60. 
<img src="https://www.benzinga.com/files/images/story/2024/1727989298_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Liberty Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Derek Podhaizer</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Marc Bianchi</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$20.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Chase Mulvehill</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Luke Lemoine</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Liberty Energy. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Liberty Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Liberty Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Liberty Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LBRT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Liberty Energy analyst ratings.</a>
<h2>Delving into Liberty Energy's Background</h2>
Liberty Energy is an oilfield services company that provides hydraulic fracturing services—mainly pressure pumping—in major basins throughout North America. Its 2020 acquisition of Schlumberger's OneStim business segment made Liberty one of the largest pressure pumpers in North America. It also added wireline operations, two Permian frac sand mines, and an expanded technological portfolio.
<h3>Breaking Down Liberty Energy's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Liberty Energy's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -2.94%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Liberty Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.35%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Liberty Energy's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.67%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Liberty Energy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.42% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Liberty Energy's debt-to-equity ratio is below the industry average at 0.24, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LBRT

Forecasting The Future: 5 Analyst Projections For Liberty Energy

Theriva biologics announces 1:25 reverse stock split

These are the upcoming stock splits for the week of August 26 to August 30, based on&nbsp;TipRanks' Stock Splits Calendar. A stock split is a corpo...

Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested

Theriva Biologics ($TOVX) is making noise in the field of immuno-oncology, supported by a promising pipeline. The stock is up 79% in the past few d...

Theriva Biologics (TOVX) Is Making Noise With a Promising Pipeline

Theriva Biologics files for common stock offering

Theriva Biologics ( ($TOVX) ) has provided an update. Theriva Biologics, Inc. has received a €2.28 million boost from the Spanish government to enh...

Theriva Biologics Secures Funding for Viral Therapy Innovation

Theriva Biologics ( ($TOVX) ) has shared an update. Theriva Biologics, Inc. is actively engaging with investors and discussing their lead product c...

Theriva Biologics Advances VCN-01 in VIRAGE Phase 2b Trial

Theriva Biologics dips 11%, prices 2.5M equity offering

Theriva Biologics dips 11%, prices $2.5M equity offering

An update from Theriva Biologics ( ($TOVX) ) is now available. Theriva Biologics, Inc. announced positive results from their Phase 1b/2a trial of S...

Theriva Biologics Advances SYN-004 in Clinical Trial

Theriva Biologics up on positive DSMC review in SYN-004 trial for transplant recipients

FBRX

GDEV

OBLG

TOVX

Screenshot 2024-08-23 at 5.34.20 PM

Theriva Biologics Receives Rare Pediatric Drug Designation From FDA For Treatment Of Retinoblastoma

Screenshot 2024-07-31 at 5.25.33 PM

Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers

Screenshot 2024-07-08 at 2.14.39 PM

Disproportionate Rise In Pancreatic Cancer Among Young Women Highlights High Unmet Need To Find Safe, Effective Treatments – Is Hope On The Horizon?

Screenshot 2024-06-06 at 5.27.01 PM

Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic Pancreatic Cancer

Screenshot 2024-04-16 at 5.31.31 PM

Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers

Screenshot 2024-03-26 at 11.16.22 PM

Utilizing Common Viruses To Combat Dangerous Cancers – Hear From The Leaders Of This Biotech

Screenshot 2024-03-13 at 5.34.18 PM

How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need

Screenshot 2024-03-05 at 6.31.45 PM

CADL

CGON

CLDI

Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology

Screenshot 2024-02-28 at 6.54.06 PM

For The First Time The US Is Set To Hit 2 Million New Cancer Cases: Theriva Biologics Presents Novel Solutions To The Deadliest Cancers

Health Care

Press Releases

Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma

Earnings

Theriva™ Biologics Reports Second Quarter 2024 Operational Highlights and Financial Results

Theriva Biologics Announces Reverse Stock Split

Theriva™ Biologics Awarded Manufacturing Funding from the Spanish Government's National Knowledge Transfer Program

Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Theriva Biologics Announces Pricing of $2.5 Million Public Offering

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Aditxt

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Apollomics

Aptevo Therapeutics

180 Life Sciences

Bio-Path Hldgs

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Entero Therapeutics

Genprex

GRI Bio

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Scorpius Holdings

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Tharimmune

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

WIIM

Theriva Biologics shares are trading higher after the company announced the Data and Safety Monitoring Committee's review outcome for its Phase 1b/2a clinical trial of SYN-004. The DSMC has recommended the study proceed to enroll cohort 3.

Comments

Theriva Biologics

매도 수량

Theriva Biologics (AMEX:TOVX) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌